Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Merck Signs MoU with Ministry of Trade, Industry & Energy and Daejeon City for New Asia Pacific BioProcessing Production Center in South Korea 2023-05-03 10:00
Completion of Enrollment in Cohorts C and G of China Phase II Clinical Study of Osemitamab (TST001) in Combination with CAPOX with or without Nivolumab as First-line Treatment of Gastric/Gastro-esophageal Junction Cancer Patients 2023-05-03 08:00
Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis 2023-05-03 00:22
Cellenkos Announces First Patient Dosed with CK0803 Cell Therapy for Treatment of Amyotrophic Lateral Sclerosis 2023-05-03 00:07
China Jo-Jo Drugstores Receives Hangzhou Municipal People's Government Quality Management Excellence Award 2023-05-02 20:30
Ascletis Announces ASC40, a First-in-Class, Once-Daily Oral FASN Inhibitor, Achieved Endpoints in Phase II Clinical Trial for Acne 2023-05-02 17:30
First Patients in Canada Imaged with Illuccix®: Now Commercially Available Nationwide 2023-05-02 05:00
I-MAB Filed 2022 Annual Report on Form 20-F 2023-05-01 20:00
Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease 2023-05-01 18:30
ZIRCON Phase III Kidney Cancer Imaging Study Presented at AUA: New Data Confirms Efficacy in Masses 2cm or Smaller 2023-05-01 08:58
OBiO and CHINAGENE reached a strategic agreement of commercial manufacturing services for gene therapy products 2023-04-29 23:20
IMG-004 demonstrated extended half-life and durable pharmacodynamic characteristics in a Phase 1 study 2023-04-28 17:00
WuXi Biologics Releases 2022 ESG Report Detailing Its Continued Commitment to Sustainability 2023-04-28 14:43
Brii Bio Publishes 2022 Environmental, Social and Governance Report 2023-04-28 09:00
Daewoong Pharmaceutical announces a Global License Agreement for DWP213388, a new drug candidate for autoimmune disease with Vitalli Bio 2023-04-28 08:58
RNAimmune Receives FDA Clearance of Investigational New Drug Application for Phase 1 Trial of RV-1730 COVID-19 Booster Vaccine 2023-04-28 00:29
Ubie signs a broad collaboration agreement with Takeda Pharmaceuticals to promote digital transformation 2023-04-27 23:00
Yuyu Pharma, Dry Eye Pipeline Mechanism of Action and Pre-clinical Results Published 2023-04-27 21:00
Fosun Collaborates with Non-profit Organizations to Provide "Chinese Solutions" to Jointly Build a Malaria-free World 2023-04-27 19:36
ASCO 2023 | Ascentage Pharma to Present Results from 4 Studies Highlighting Extended Therapeutic Potential of Lead Drug Candidates 2023-04-27 17:44
1 71 72 73 74 75 377